Similar articles

• Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET).

  Brunner-La Rocca HP, Kaiser C, Pfisterer M; BASKET Investigators. Brunner-La Rocca HP, et al. Eur Heart J. 2007 Mar;28(6):719-25. doi: 10.1093/eurheartj/ehl490. Epub 2007 Feb 13. Eur Heart J. 2007. PMID: 17298975 Clinical Trial.
• Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.

  Zellweger MJ, Kaiser C, Brunner-La Rocca HP, Buser PT, Osswald S, Weiss P, Mueller-Brand J, Pfisterer ME; BASKET Investigators. Zellweger MJ, et al. J Nucl Med. 2008 Apr;49(4):550-6. doi: 10.2967/jnumed.107.046771. Epub 2008 Mar 14. J Nucl Med. 2008. PMID: 18344439 Clinical Trial.
• Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design.

  Pfisterer M, Bertel O, Bonetti PO, Brunner-La Rocca HP, Eberli FR, Erne P, Galatius S, Hornig B, Kiowski W, Pachinger O, Pedrazzini G, Rickli H, De Servi S, Kaiser C; BASKET-PROVE Investigators. Pfisterer M, et al. Am Heart J. 2008 Apr;155(4):609-14. doi: 10.1016/j.ahj.2007.11.011. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18371466 Clinical Trial.
• Promise and challenges of bioabsorbable stents.

  Waksman R. Waksman R. Catheter Cardiovasc Interv. 2007 Sep;70(3):407-14. doi: 10.1002/ccd.21176. Catheter Cardiovasc Interv. 2007. PMID: 17722019 Review.
• Surgical therapies for post-myocardial infarction patients.

  McCarthy PM. McCarthy PM. Am J Cardiol. 2008 Sep 8;102(5A):42G-46G. doi: 10.1016/j.amjcard.2008.06.010. Am J Cardiol. 2008. PMID: 18722191 Review.